1. Home
  2. XOMA vs BRW Comparison

XOMA vs BRW Comparison

Compare XOMA & BRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • BRW
  • Stock Information
  • Founded
  • XOMA N/A
  • BRW 1987
  • Country
  • XOMA United States
  • BRW United States
  • Employees
  • XOMA N/A
  • BRW N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • BRW Trusts Except Educational Religious and Charitable
  • Sector
  • XOMA Health Care
  • BRW Finance
  • Exchange
  • XOMA Nasdaq
  • BRW Nasdaq
  • Market Cap
  • XOMA 298.3M
  • BRW 308.8M
  • IPO Year
  • XOMA N/A
  • BRW N/A
  • Fundamental
  • Price
  • XOMA $28.72
  • BRW $7.27
  • Analyst Decision
  • XOMA Strong Buy
  • BRW
  • Analyst Count
  • XOMA 2
  • BRW 0
  • Target Price
  • XOMA $57.00
  • BRW N/A
  • AVG Volume (30 Days)
  • XOMA 32.3K
  • BRW 222.1K
  • Earning Date
  • XOMA 08-06-2024
  • BRW 01-01-0001
  • Dividend Yield
  • XOMA N/A
  • BRW 15.59%
  • EPS Growth
  • XOMA N/A
  • BRW N/A
  • EPS
  • XOMA N/A
  • BRW N/A
  • Revenue
  • XOMA $5,811,000.00
  • BRW N/A
  • Revenue This Year
  • XOMA $349.94
  • BRW N/A
  • Revenue Next Year
  • XOMA $28.50
  • BRW N/A
  • P/E Ratio
  • XOMA N/A
  • BRW N/A
  • Revenue Growth
  • XOMA 73.10
  • BRW N/A
  • 52 Week Low
  • XOMA $13.48
  • BRW $7.15
  • 52 Week High
  • XOMA $28.25
  • BRW $8.30
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 64.67
  • BRW 62.41
  • Support Level
  • XOMA $24.36
  • BRW $6.90
  • Resistance Level
  • XOMA $27.05
  • BRW $7.15
  • Average True Range (ATR)
  • XOMA 1.27
  • BRW 0.11
  • MACD
  • XOMA 0.40
  • BRW 0.04
  • Stochastic Oscillator
  • XOMA 95.66
  • BRW 97.40

About XOMA XOMA Corporation

XOMA Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

About BRW Saba Capital Income & Opportunities Fund SBI

Saba Capital Income & Opportunities Fund t is a diversified, closed-end management investment company. It seeks to provide investors with a high level of current income, with a secondary goal of capital appreciation. It invests globally in debt and equity securities of public and private companies, which includes, investing in closed-end funds, public and private debt instruments, and other securities.

Share on Social Networks: